Cohen EN - Search Results

1

Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy.

Iwase T, Cohen EN, Gao H, Alexander A, Kai M, Chiv V, Wang X, Krishnamurthy S, Liu D, Shen Y, Kida K, Reuben A, Layman RM, Ramirez DL, Tripathy D, Moulder SL, Yam C, Valero V, Lim B, Reuben JM, Ueno NT. Iwase T, et al. Among authors: cohen en. Clin Cancer Res. 2024 Jun 3;30(11):2424-2432. doi: 10.1158/1078-0432.CCR-23-2947. Clin Cancer Res. 2024. PMID: 38629963 Clinical Trial.

2

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.

Ferrajoli A, Lee BN, Schlette EJ, O'Brien SM, Gao H, Wen S, Wierda WG, Estrov Z, Faderl S, Cohen EN, Li C, Reuben JM, Keating MJ. Ferrajoli A, et al. Among authors: cohen en. Blood. 2008 Jun 1;111(11):5291-7. doi: 10.1182/blood-2007-12-130120. Epub 2008 Mar 11. Blood. 2008. PMID: 18334676 Free PMC article. Clinical Trial.

3

Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines.

Shearer WT, Ochs HD, Lee BN, Cohen EN, Reuben JM, Cheng I, Thompson B, Butel JS, Blancher A, Abbal M, Aviles H, Sonnenfeld G. Shearer WT, et al. Among authors: cohen en. J Allergy Clin Immunol. 2009 Apr;123(4):900-5. doi: 10.1016/j.jaci.2008.12.016. Epub 2009 Feb 20. J Allergy Clin Immunol. 2009. PMID: 19232702

4

Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.

Jain N, Reuben JM, Kantarjian H, Li C, Gao H, Lee BN, Cohen EN, Ebarb T, Scheinberg DA, Cortes J. Jain N, et al. Among authors: cohen en. Cancer. 2009 Sep 1;115(17):3924-34. doi: 10.1002/cncr.24468. Cancer. 2009. PMID: 19536894 Free PMC article. Clinical Trial.

5

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A. Krishnamurthy S, et al. Among authors: cohen en. Cancer. 2010 Jul 15;116(14):3330-7. doi: 10.1002/cncr.25145. Cancer. 2010. PMID: 20564098 Free article.

6

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.

Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, Reuben JM, Lewis MT, Woodward WA. Debeb BG, et al. Mol Cancer. 2010 Jul 8;9:180. doi: 10.1186/1476-4598-9-180. Mol Cancer. 2010. PMID: 20615238 Free PMC article.

7

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors.

Naing A, Reuben JM, Camacho LH, Gao H, Lee BN, Cohen EN, Verschraegen C, Stephen S, Aaron J, Hong D, Wheler J, Kurzrock R. Naing A, et al. Among authors: cohen en. J Cancer. 2011 Feb 10;2:81-9. doi: 10.7150/jca.2.81. J Cancer. 2011. PMID: 21326629 Free PMC article.

8

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.

Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A, Wang X, Lodhi A, Krishnamurthy S, Hortobagyi GN, Cristofanilli M, Lucci A, Woodward WA. Reuben JM, et al. Among authors: cohen en. Eur J Cancer. 2011 Jul;47(10):1527-36. doi: 10.1016/j.ejca.2011.01.011. Epub 2011 Feb 19. Eur J Cancer. 2011. PMID: 21334874 Free PMC article.

9

Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.

De Giorgi U, Cohen EN, Gao H, Mego M, Lee BN, Lodhi A, Cristofanilli M, Lucci A, Reuben JM. De Giorgi U, et al. Among authors: cohen en. Cancer Biol Ther. 2011 May 1;11(9):812-5. doi: 10.4161/cbt.11.9.15178. Epub 2011 May 1. Cancer Biol Ther. 2011. PMID: 21358274 Free PMC article.

10

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.

Mego M, Mani SA, Lee BN, Li C, Evans KW, Cohen EN, Gao H, Jackson SA, Giordano A, Hortobagyi GN, Cristofanilli M, Lucci A, Reuben JM. Mego M, et al. Among authors: cohen en. Int J Cancer. 2012 Feb 15;130(4):808-16. doi: 10.1002/ijc.26037. Epub 2011 Apr 27. Int J Cancer. 2012. PMID: 21387303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters